Hinge Bio, Inc. — Form D/A

Hinge Bio, Inc. of BURLINGAME, CA, a company, filed a Form D amendment with the SEC on 2021-02-01. The offering totals $18.0M, of which $18.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Daniel CaponDirectorBurlingame, CA
Malcolm GefterDirectorBurlingame, CA
Carin RollinsDirectorBurlingame, CA
William Misha UngerDirectorBurlingame, CA
Daniel CaponExecutive OfficerBurlingame, CA
Carin RollinsExecutive OfficerBurlingame, CA
John Misha PetkevichDirectorBurlingame, CA
Alex E SilversteinDirectorBurlingame, CA
Malcolm E GefterDirectorBurlingame, CA
Jeffrey Misha Long-McGieDirectorBurlingame, CA
Harold E Selick, PhDDirectorBurlingame, CA
Harold E Selick, PhDExecutive OfficerBurlingame, CA
Miriam Misha SiekevitzExecutive OfficerBurlingame, CA
Daniel J CaponDirectorBurlingame, CA
Miriam D SiekevitzExecutive OfficerBurlingame, CA
Malcolm L GefterDirectorBurlingame, CA
William D UngerDirectorBurlingame, CA
Samuel Misha SaksDirectorBurlingame, CA
Carin M RollinsDirectorBurlingame, CA
Carin M RollinsExecutive OfficerBurlingame, CA
J. Misha PetkevichDirectorBethesda, MD

Other filings by this issuer (5)

FiledFormOfferingSold
2025-01-15D$40.8M$30.6M
2021-01-14D/A$18.0M$12.7M
2021-01-07D$18.0M$10.3M
2020-04-28D/A$19.0M$18.2M
2020-02-27D$19.0M$18.2M

More